Sage Journals: Discover world-class research

Retricted access

Other

First published 2000-10

New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms

Joseph A. DiMasi

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2017-12

Do innovative activities matter to Indian drug and pharmaceutical firms? An application to export performance

Shilpi Tyagi, DK Nauriyal

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2014-2

Cost efficiency of pharmaceutical firms manufacturing drugs for specific diseases prevalent in India: A data envelopment analysis approach

Sumanta Das, GN Patel

Journal of Medical Marketing: Device,Diagnostic and Pharmaceutical Marketing

Retricted access

Research article

First published 1994-7

Handling a Pharmaceutical Recall: Why it Pays to Do it Right

Bruce R. Parker, Geraldine Valentino

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2013-02

Tumor Bank Lends Expertise to Drug Firms

Genetic Engineering & Biotechnology News

Retricted access

Research article

First published 2019-7

U.S. Health Care in the Trump Era: A Data Update

David U. Himmelstein, Steffie Woolhandler, Clare Fauke

International Journal of Social Determinants of Health and Health Services

Retricted access

Meeting report

First published 2013-10

Drug Firms,the Codification of Diagnostic Categories,and Bias in Clinical Guidelines

Lisa Cosgrove, Emily E. Wheeler

The Journal of Law,Medicine & Ethics

Retricted access

Research article

First published 2022-04

Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?

Annapoornima M. Subramanian, Moren Lévesque, Vareska Van De Vrande

Production and Operations Management

Retricted access

Research article

First published 2008-08

Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Commitment Studies;Availability

Biotechnology Law Report

Retricted access

Research article

First published 2003-1

The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs

Kirsten Ely, Paul J. Simko, L. G. Thomas

Journal of Accounting,Auditing & Finance

Search results